Skip to main content

Cormorant Asset Management, LP

Position in CNTA — Centessa Pharmaceuticals plc

CIK 1583977 BOSTON, MA

Position in CNTA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,050,000
-20.8% QoQ
Ownership
0.679%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CNTA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 1,050,000
2025-12-31 1,325,000
2025-09-30 1,925,000
2025-06-30 2,086,600
2025-03-31 2,261,600
2024-12-31 2,561,600
2024-09-30 2,561,600
2024-06-30 1,611,600
2024-03-31 561,600
2023-12-31 561,600
2023-09-30 561,600
2023-06-30 561,600
2023-03-31 561,600
2022-12-31 561,600
2022-09-30 1,972,728
2022-06-30 2,927,273
2022-03-31 2,489,894
2021-12-31 2,489,894
2021-09-30 1,727,273
2021-06-30 1,427,273